Carregant...
Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia
VYXEOS(™) is a liposomal-encapsulated formulation of daunorubicin and cytarabine delivering a fixed, synergistic 1:5 molar ratio (hereafter referred to as daunorubicin/cytarabine liposome). Daunorubicin/cytarabine liposome is approved in several countries worldwide for the treatment of adults with t...
Guardat en:
| Publicat a: | Drugs |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer International Publishing
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6314217/ https://ncbi.nlm.nih.gov/pubmed/30511323 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-018-1022-3 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|